Reference health
Herzinsuffizienz: Leitlinien-Update der ESC 2023
15/15 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 15 checked references that resolve
resolves10.1056/nejmoa1911303
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
resolves10.1056/nejmoa2206286
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
resolves10.1093/eurheartj/ehad195
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
resolves10.1016/s0140-6736(22)02076-1
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
resolves10.1016/j.jacc.2023.03.426
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction
resolves10.1093/eurheartj/ehad266
Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice
resolves10.1038/s41591-021-01659-1
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
resolves10.1016/s0140-6736(22)02083-9
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
resolves10.1016/s0140-6736(20)32339-4
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
resolves10.1056/nejmoa2025845
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
resolves10.1056/nejmoa2110956
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
resolves10.1093/eurheartj/ehab777
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1007/s00059-023-05221-2"><img src="https://citestamp.com/citestamped/10.1007/s00059-023-05221-2/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1007/s00059-023-05221-2)